Progenics Pharmaceuticals, Inc. Sets 4Q And Year-End 2013 Financial Results Call For March 13

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TARRYTOWN, N.Y., March 10, 2014 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company focused on developing innovative ways to target and treat prostate cancer, announced today that it will host a conference call and webcast to review fourth quarter and full-year 2013 financial results on Thursday, March 13, at 8:30 a.m. ET.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC